Supervision of Facilitators in a Multisite Study: Goals, Process, and Outcomes
Wu
Elwin
contributor
Columbia University. Social Work
Witte
Susan S.
contributor
Columbia University. Social Work
El-Bassel
Nabila
contributor
Columbia University. Social Work
Gilbert
Louisa
contributor
Columbia University. Social Work
NIMH Multisite HIV/STD Prevention Trial for African American Couples Group
author
Columbia University. Social Work
originator
text
Articles
2008
manuscript version
English
Objective: To describe the aims, implementation, and desired outcomes of facilitator supervision for both interventions (treatment and control) in Project Eban and to present the Eban Theoretical Framework for Supervision that guided the facilitators’ supervision. The qualifications and training of supervisors and facilitators are also described. Design: This article provides a detailed description of supervision in a multisite behavioral intervention trial. The Eban Theoretical Framework for Supervision is guided by 3 theories: cognitive behavior therapy, the Life-long Model of Supervision, and "Empowering supervisees to empower others: a culturally responsive supervision model." Methods: Supervision is based on the Eban Theoretical Framework for Supervision, which provides guidelines for implementing both interventions using goals, process, and outcomes. Results: Because of effective supervision, the interventions were implemented with fidelity to the protocol and were standard across the multiple sites. Conclusions: Supervision of facilitators is a crucial aspect of multisite intervention research quality assurance. It provides them with expert advice, optimizes the effectiveness of facilitators, and increases adherence to the protocol across multiple sites. Based on the experience in this trial, some of the challenges that arise when conducting a multisite randomized control trial and how they can be handled by implementing the Eban Theoretical Framework for Supervision are described.
Behavioral sciences
Public health
Journal of Acquired Immune Deficiency Syndromes
49
Supplement 1
S59
S67
2008-09-01
http://dx.doi.org/10.1097/QAI.0b013e3181844807
1525-4135
http://hdl.handle.net/10022/AC:P:14282
NNC
NNC
2012-07-30 15:53:28 -0400
2013-05-03 16:38:13 -0400
8289
eng